60 Degrees PharmaceuticalsSXTP -2.23%44 Days Payable is 1,563.45 as of Mar. 2026, which is 173% above its 10-year median of 572.98. GuruFocus rates SXTP with a GF Score™ of 44/100 and a GF Value™ of $2.05 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 703 Biotechnology companies, 60 Degrees Pharmaceuticals ranks better than 81.37% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, 60 Degrees Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
60 Degrees Pharmaceuticals Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 60 Degrees Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where 60 Degrees Pharmaceuticals's Days Payable falls into.
60 Degrees Pharmaceuticals Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
60 Degrees Pharmaceuticals (SXTP) has a Days Payable of 1,563.45 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 60 Degrees Pharmaceuticals and its competitors. This is 173% above median its historical median of 572.98. Over the past decade, 60 Degrees Pharmaceuticals' Days Payable has ranged from 422.11 to 717.68. According to the industry distribution chart, 60 Degrees Pharmaceuticals ranks #131 out of 703 companies in the Biotechnology industry, placing it in the top 18.6%.
Is 60 Degrees Pharmaceuticals' Days Payable too high?
60 Degrees Pharmaceuticals' current Days Payable of 1,563.45 is 173% above median its 10-year median of 572.98. Over the past 10 years, this metric has ranged from a low of 422.11 to a high of 717.68. The Biotechnology industry median Days Payable is 113.76. 60 Degrees Pharmaceuticals' value of 1,563.45 is 1274.3% above this industry median. Based on the distribution chart, 60 Degrees Pharmaceuticals ranks #131 out of 703 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, 60 Degrees Pharmaceuticals has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 60 Degrees Pharmaceuticals' Days Payable compare to GLMD and FBLG?
According to the Biotechnology industry distribution chart, 60 Degrees Pharmaceuticals ranks #131 out of 703 companies for Days Payable. This places 60 Degrees Pharmaceuticals in the top 19% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.76. 60 Degrees Pharmaceuticals' value of 1,563.45 is 1274.3% above this benchmark. Historically, 60 Degrees Pharmaceuticals' own Days Payable has ranged from 422.11 to 717.68 over the past decade. While the company's 10-year median is 572.98 vs. the industry median of 113.76, 60 Degrees Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 60 Degrees Pharmaceuticals's current Days Payable of 1,563.45 is 1274.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 60 Degrees Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 60 Degrees Pharmaceuticals's current Days Payable is 1,563.45, which is 173% above median its own 10-year median of 572.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 60 Degrees Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals (SXTP) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.05, compared to a current price of $1.75 — trading 14.6% below its estimated fair value. The current Days Payable is 1,563.45, which is 173% above median its 10-year median of 572.98 and 1274.3% above the Biotechnology industry median of 113.76. 60 Degrees Pharmaceuticals' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For 60 Degrees Pharmaceuticals (SXTP), the current Days Payable is 1,563.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 60 Degrees Pharmaceuticals (SXTP) Overvalued in 2026?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals stock appears to be undervalued.
The current stock price of $1.75 is trading 14.6% below its estimated GF Value™ of $2.05.
GuruFocus considers 60 Degrees Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for SXTP:
Days Payable: 1,563.45 (173% above median its 10-year median of 572.98)
GF Value™: $2.05 vs. price of $1.75 (14.6% below fair value)
Industry Position: 1274.3% above the Biotechnology median (#131 of 703)
No single metric tells the full story. See the SXTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
44GF Score
Get the complete analysis for SXTP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SXTP has been successfully added to your 
